These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 474008)

  • 21. The effect of adding iron to mucin on the enhancement of virulence for mice of Salmonella typhi strain TY 2.
    Powell CJ; DeSett CR; Lowenthal JP; Berman S
    J Biol Stand; 1980; 8(1):79-85. PubMed ID: 6156943
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thymosterine B stimulation of serum antibodies in rats inoculated with Salmonella typhi TH vaccine].
    Potop I; Briese MA; Milcu SM
    Endocrinologie; 1980; 18(4):239-41. PubMed ID: 7209356
    [No Abstract]   [Full Text] [Related]  

  • 23. Can a 'flawless' live vector vaccine strain be engineered?
    Galen JE; Levine MM
    Trends Microbiol; 2001 Aug; 9(8):372-6. PubMed ID: 11514219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of the number of times of typhoid antigen administration on the process of antibody formation].
    Egorova NB; Moskatel'nikova TT
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):135-6. PubMed ID: 1239150
    [No Abstract]   [Full Text] [Related]  

  • 25. Ribonucleic acid-protein purified from Salmonella typhi involved in experimental immunity.
    Molinari JL; Yépez L; Tato P; Méndez L
    Ann Immunol (Paris); 1981; 132D(1):25-41. PubMed ID: 7347554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine.
    Cancellieri V; Fara GM
    J Infect Dis; 1985 Mar; 151(3):482-4. PubMed ID: 3882850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Baptisia tinctoria in the treatment of typhoid: its possible role in inducing antibody formation.
    Banerji P; Banerji P; Das GC; Islam A; Mishra SK; Mukhopadhyay S
    J Complement Integr Med; 2012 Jul; 9():Article 15. PubMed ID: 22850071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antibodies against Salmonella typhi OmpC porin by naked DNA immunization.
    López-Macías C; López-Hernández MA; González CR; Isibasi A; Ortiz-Navarrete V
    Ann N Y Acad Sci; 1995 Nov; 772():285-8. PubMed ID: 8546410
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of staphylococcal exotoxin on immune response to thymus-dependent and thymus-independent antigens].
    Kunevich NP
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):112-3. PubMed ID: 7445864
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conjugate vaccines against bacterial infections: typhoid fever].
    Paniagua J; García JA; López CR; González CR; Isibasi A; Kumate J
    Salud Publica Mex; 1992; 34(3):268-73. PubMed ID: 1377407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological characteristics of some drug resistant "Salmonella typhi" strains (author's transl)].
    Dimache G; Palade R; Dimache V; Surdeanu M; Iordanescu S; Cosman M
    Ann Microbiol (Paris); 1977; 128A(4):401-12. PubMed ID: 911107
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thiamphenicol and immune response. Latest study in rabbits immunized with various antigens].
    Barba G; Valguarnera G; Merlo N
    Boll Soc Ital Biol Sper; 1972 Sep; 48(17):477-80. PubMed ID: 4643388
    [No Abstract]   [Full Text] [Related]  

  • 33. [Split immune tolerance of mice to S. typhi Vi antigen].
    Korukova AA; Filitis LN; Solov'ev VV
    Biull Eksp Biol Med; 1972 Oct; 73(10):54-7. PubMed ID: 4673785
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
    Saxena M; Percheson PB; Di Fabio JL
    J Infect Dis; 1993 Aug; 168(2):522-3. PubMed ID: 8336003
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of 7S and 19S antibodies on the primary response to Salmonella typhi antigens.
    Fink CW; LoSpalluto JJ
    Immunology; 1967 Mar; 12(3):259-66. PubMed ID: 6020396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of the effect of trichloroethylene poisoning on the formation of antibodies to the O-antigen of Sal. typhi].
    Shmuter LM
    Biull Eksp Biol Med; 1972 Aug; 73(8):77-80. PubMed ID: 4673783
    [No Abstract]   [Full Text] [Related]  

  • 39. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
    Sztein MB; Wasserman SS; Tacket CO; Edelman R; Hone D; Lindberg AA; Levine MM
    J Infect Dis; 1994 Dec; 170(6):1508-17. PubMed ID: 7995991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.